The Klow Stack: A Four-Peptide Approach to Inflammation, Gut Lining & Skin

Some women come to me with a gut problem. Some come with a skin problem. A surprising number have both — and no one has ever connected the two for them. The Klow stack is the peptide combination that comes up most often when inflammation itself is the through-line: BPC‑157, TB‑500, GHK‑Cu, and the peptide that gives this stack its "K" — KPV.

What Is the Klow Peptide Stack?

Klow is the most comprehensive of the combination protocols, layering four peptides into a single compounded injection:

• BPC‑157 — studied for repair of the gut lining, tendon, ligament, and muscle, with anti-inflammatory effects in animal models.
• TB‑500 (Thymosin Beta‑4) — involved in cell migration and wound healing.
• GHK‑Cu — the copper peptide associated with collagen synthesis, tissue remodeling, and antioxidant activity.
• KPV — a three-amino-acid fragment of alpha‑MSH, studied specifically for its anti-inflammatory signaling.

If Wolverine is about repair and Glow is about repair plus skin quality, Klow is about repair, skin, and quieting the inflammatory noise underneath both.

KPV: Small Peptide, Specific Job

KPV is remarkably small — just three amino acids (lysine, proline, valine) clipped from the tail of alpha‑melanocyte‑stimulating hormone, a molecule your body already uses in immune regulation. What makes KPV interesting to researchers is that it appears able to enter cells and interfere with inflammatory signaling pathways from the inside, rather than only acting at the cell surface.

The research attention has clustered in two places, and they're precisely the two places midlife women most often struggle:

• Inflammatory conditions of the intestine — where preclinical work has examined KPV's effect on colitis models and intestinal barrier function.
• Inflammatory skin conditions — including interest in eczema, psoriasis, and acne, where alpha‑MSH biology is already relevant.

Gut and skin aren't separate systems having separate problems. They're two surfaces of the same immune conversation.

The Gut–Skin Axis: Why This Combination Makes Sense

The gut–skin axis is one of the most clinically useful concepts in functional medicine. Your intestinal barrier, microbiome, and immune system are in constant dialogue, and skin often reflects that conversation. It's why so many women with rosacea, eczema, or unexplained flushing also describe bloating, irregularity, or food reactivity — and why treating the skin alone so often plateaus.

For women, hormones add a third voice. Estrogen and progesterone influence gut motility, microbiome composition, mast cell behavior, and skin barrier function. During perimenopause — when those hormones swing rather than glide — I frequently see previously stable gut and skin conditions destabilize at the same time. Women are told these are two coincidental new problems. They usually aren't.

The Klow stack is built for that convergence: BPC‑157 and KPV oriented toward the gut lining and inflammatory signaling, GHK‑Cu and TB‑500 oriented toward tissue repair and skin remodeling.

What Klow Doesn't Replace

I'll be blunt, because it matters clinically: a peptide stack is not a substitute for finding out why you're inflamed. Anyone considering Klow should be doing the investigative work alongside it — comprehensive stool analysis where indicated, hormone assessment, food-reactivity and nutrient evaluation, and a genuine look at sleep and stress physiology. That root-cause work is where I spend my time with patients. Peptides can shift the terrain; they don't answer the question of what put you there.

Nor is Klow a treatment for diagnosed inflammatory bowel disease or an autoimmune skin condition. If you carry one of those diagnoses, this is a conversation to have jointly with your gastroenterologist or dermatologist — not a swap for the care they're providing.

Who Might Be a Candidate

The women who ask about Klow are usually dealing with a stubborn combination — digestive symptoms that haven't fully resolved with dietary work, plus reactive or inflamed skin, plus the recovery slowdown and joint aches that so often arrive alongside perimenopause. They've usually done the elimination diets and the expensive serums. What they haven't had is a strategy that treats the inflammation as one problem instead of four.

Frequently Asked Questions

Should I start with Wolverine, Glow, or Klow?

It depends on what's loudest. Isolated injury or recovery: Wolverine. Skin and collagen priority: Glow. Active inflammation across gut and skin: Klow. That triage belongs in a clinical conversation, not on a menu.

How is it administered?

A small subcutaneous injection with a fine insulin-style needle, self-administered at home after training from the prescribing provider. Protocols are typically run in defined cycles rather than indefinitely.

Can I use this while on other medications?

Possibly — but interactions and underlying diagnoses have to be reviewed first by a licensed prescribing provider. Bring your full medication and supplement list to that conversation.

Is there an oral form of KPV?

KPV is available in other delivery forms in some settings; the version discussed here is the injectable four-peptide combination. Which form fits you is a clinical decision based on whether the target is systemic or gut-localized.